1149 GMT - Sales of GSK s respiratory syncytial virus vaccine Arexvy are expected to peak at $4 billion and could surpass consensus, Jefferies analysts say in a note. This drug, together with. | May 30, 2023
1111 GMT - Greencore s 1H adjusted EBIT of GBP3.6 million was lower on year, but ahead of analysts expectations, Shore Capital s Clive Black and Darren Shirley say in a note. The convenience-food. | May 30, 2023